XTX Topco’s Burning Rock Biotech BNR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,102
Closed -$10.3K 1859
2023
Q4
$10.3K Buy
+1,102
New +$10.1K ﹤0.01% 1428
2023
Q2
Sell
-1,343
Closed -$37.7K 1431
2023
Q1
$37.7K Buy
+1,343
New +$40.2K 0.01% 1189
2022
Q4
Sell
-2,520
Closed -$60K 1141
2022
Q3
$60K Buy
+2,520
New +$81.3K 0.01% 1009

Other funds holding BNR

XTX Topco's BNR Position: Q1 2024 in Review

XTX Topco sold out of Burning Rock Biotech (BNR) in Q1 2024, closing a stake of 1,102 shares — an estimated $10.3K sold.

XTX Topco first reported a position in BNR in Q3 2022 and held it in 3 quarters. The position peaked at $60K in Q3 2022. 20 funds tracked by Wall St. Rank hold BNR as of Q1 2024.

  • XTX Topco reported no remaining Burning Rock Biotech position as of Q1 2024 after selling out during the quarter.
  • XTX Topco sold 1,102 Burning Rock Biotech shares in Q1 2024, an estimated $10.3K.
  • XTX Topco first reported a position in Burning Rock Biotech in Q3 2022 and held it in 3 quarters.
  • XTX Topco's Burning Rock Biotech position peaked at $60K in Q3 2022.
  • 20 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q1 2024.

Based on XTX Topco's 13F filing for Q1 2024, filed 13 May 2024.